Top 5 Genomics Companies in the World

2. Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)

Latest Market Capitalization: $6.7 billion

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) is a biotechnology company that develops treatments for several hereditary and familial diseases. The firm has several research and development collaborations within the genomics sector, through which it seeks to combine its RNA treatments with gene treatments for a customized approach.

By the end of this year’s second quarter, 27 out of the 910 hedge funds surveyed by Insider Monkey had held a stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS). Mark Lampert’s Biotechnology Value Fund / BVF Inc is the biggest shareholder among these due to its $116 million investment.

Follow Ionis Pharmaceuticals Inc (NASDAQ:IONS)